Neuromyelitis optica-AQP4: An update

Current Rheumatology Reports

Volumn 13, Issue 6, 2011, Pages 496-505

  Benavente, Emilio ^a   Paira, Sergio ^a  

^a Hospital Jose M Cullen   (Argentina)

Author keywords

AQP4; Aquaporin 4; Devic disease; Neuromyelitis optica; NMO; Optic neuritis; Transverse myelitis; Vasculitis

Indexed keywords

ANTINUCLEAR ANTIBODY; AQUAPORIN 4; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN G; METHOTREXATE; METHYLPREDNISOLONE; MITOXANTRONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RITUXIMAB; RO ANTIBODY;

ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL TRIAL (TOPIC); DEMYELINATING DISEASE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; ENCEPHALOMYELITIS; HEART DISEASE; HUMAN; MULTIPLE SCLEROSIS; MYELITIS; MYELOID LEUKEMIA; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPEN STUDY; OPTIC NEURITIS; PATHOPHYSIOLOGY; PLASMAPHERESIS; PREDICTION; PROGNOSIS; RELAPSE; SENSITIVITY AND SPECIFICITY; SPINAL CORD DISEASE; SPINAL CORD LESION;

AQUAPORIN 4; AUTOANTIBODIES; BIOLOGICAL MARKERS; CLINICAL TRIALS AS TOPIC; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; MALE; NEUROMYELITIS OPTICA; PLASMA EXCHANGE; PROGNOSIS; SPINAL CORD;

EID: 80755190138     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-011-0211-9     Document Type: Article

References (96)

1. TC Allbutt 1870 On the ophthalmoscopic signs of spinal disease Lancet 1 76 78
2. E Devic 1894 Myélite subaiguë compliquée de névrite optique Bull Med (Paris) 8 1033 1034
3. DM Wingerchuk WF Hogancamp PC O'Brien BG Weinshenker 1999 The clinical course of neuromyelitis optica (Devic's syndrome) Neurology 53 1107 1114 10496275 1:STN:280:DyaK1MvisVGqtg%3D%3D (Pubitemid 29442132)
4. DM Wingerchuk VA Lennon SJ Pittock CF Lucchinetti BG Weinshenker 2006 Revised diagnostic criteria for neuromyelitis optica Neurology 66 1485 1489 16717206 1:STN:280:DC%2BD283ovVKitw%3D%3D (Pubitemid 43958540)
5. VA Lennon DM Wingerchuk TJ Kryzer SJ Pittock CF Lucchinetti K Fujihara, et al. 2004 A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis Lancet 364 9451 2106 2112 15589308 1:CAS:528: DC%2BD2cXhtVKltbvF (Pubitemid 39626806)
6. J Seze C Lebrun T Stojkovic, et al. 2003 Is Devic's neuromyelitis optica a separate disease? A comparative study with multiple sclerosis Mult Scler 9 521 525 14582780 (Pubitemid 37287734)
7. V Harisdangkul D Doorenbos SH Subramony 1995 Lupus transverse myelopathy: better outcome with early recognition and aggressive high-dose intravenous corticosteroid pulse treatment J Neurol 242 326 331 7643142 1:STN:280: DyaK2MzntVymtg%3D%3D
8. R Bergamaschi A Ghezzi 2004 Devic's neuromyelitis optica: clinical features and prognostic factors Neurol Sci 25 S364 S367 15727235 (Pubitemid 39600433)
9. P Cabre O Heinzlef H Merle, et al. 2001 MS and neuromyelitis optica in Martinique (French West Indies) Neurology 56 507 514 11222796 1:STN:280:DC%2BD3M7ps1Kgsw%3D%3D (Pubitemid 32172877)
10. H Merle S Olindo M Bonnan, et al. 2007 Natural history of the visual impairment of relapsing neuromyelitis optica Ophthalmology 114 4 810 815 17141316 Epub 2006 Nov 30
11. RM Papais-Alvarenga CM Miranda-Santos M Puccioni-Sohler 2002 Optic neuromyelitis syndrome in Brazilian patients J Neurol Neurosurg Psychiatry 73 4 429 435 12235313 1:STN:280:DC%2BD38vps1WmtQ%3D%3D
12. BH Balser 1936 Neuromyelitis optica Brain 59 353 365
13. Erb W. Über das Zusammenkommen von Neuritis optica und Myelitis subacute. Arch Psychiatr Nervenkr 1879-1980;1:146-57.
14. GM Beck 1927 A case of diffuse myelitis associated with optic neuritis Brain 50 687 703
15. BG Weinshenker 2003 Neuromyelitis optica: what it is and what it might be Lancet 361 889 890 12648964 (Pubitemid 36332102)
16. HB Field 1961 A case of neuomyelitis optica Ill Med J 119 362 367 13699355 1:STN:280:DyaF3c%2FhvVOrtQ%3D%3D
17. SJ Pittock VA Lennon K Krecke, et al. 2006 Brain abnormalities in neuromyelitis optica Arch Neurol 63 390 396 16533966
18. RJ Keefe 1957 Neuromyelitis optica with increased intracranial pressure Arch Ophthal 57 110 111 1:STN:280:DyaG2s%2FislCjuw%3D%3D
19. JI O'Riordan HL Gallagher AJ Thompson, et al. 1996 Clinical, CSF, and MRI findings in Devic's neuromyelitis optica J Neurol Neurosurg Psychiatry 60 382 387 8774400 (Pubitemid 26118744)
20. S Jarius D Franciotta F Paul, et al. 2010 Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance J Neuroinflammation 7 52 20825655 In the cohort analyzed in this study, testing for CSF AQP4 antibodies did not improve the sensitivity and specificity of the current diagnostic criteria for NMO. The substantial lack of intrathecal AQP4 antibody synthesis in patients with NMOSD may reflect the unique localization of the target antigen at the blood-brain barrier and is important for our understanding of the immunopathogenesis of the disease.
21. K Tashiro K Ito Y Maruo, et al. 1987 MR imaging of spinal cord in Devic disease J Comput Assist Tomogr 11 516 517 3571597 1:STN:280:DyaL2s7psFKgsQ%3D%3D (Pubitemid 17081525)
22. J de Seze G Stojkovic G Breteau, et al. 2001 Acute myelopathies. Clinical, laboratory and outcome profiles in 79 cases Brain 124 1509 1521 11459743 (Pubitemid 32726765)
23. B Cree D Goodin S Hauser 2002 Neuromyelitis optica Semin Neurol 22 2 105 122 12524556 (Pubitemid 35425276)
24. J Cabrera-Gomez Quevedo-Sotolongo A Gonzalez-Quevedo, et al. 2007 Brain magnetic resonance imaging findings neuromyelitis optica Mult Scler 13 186 192 17439883 (Pubitemid 46592770)
25. SJ Pittock BG Weinshenker CF Lucchinetti DM Wingerchuk JR Corboy VA Lennon 2006 Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression Arch Neurol 63 7 964 968 16831965 (Pubitemid 44036298)
26. F Barkhof P Scheltens J Valk C Waalewijn BM Uitdehaag CH Polman 1991 Serial quantitative MR assessment of optic neuritis in a case of neuromyelitis optica, using gadolinium-"enhanced" STIR imaging Neuroradiology 33 70 71 2027451 1:STN:280:DyaK3M3is1KitA%3D%3D
27. VA Lennon TJ Kryzer SJ Pittock AS Verkman SR Hinson 2005 IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel J Exp Med 202 4 473 477 16087714 1:CAS:528:DC%2BD2MXosVarsr4%3D Epub 2005 Aug 8 (Pubitemid 41186945)
28. M Amiry-Moghaddam OP Ottersen 2003 The molecular basis of water transport in the brain Nat Rev Neurosci 4 12 991 1001 14682361 1:CAS:528: DC%2BD3sXpslGhurs%3D (Pubitemid 37486675)
29. JF Kurtzke CS Park SJ Oh 1968 Multiple sclerosis in Korea. Clinical features and prevalence J Neurol Sci 6 3 463 481 5710145 1:STN:280: DyaF1M7ht1Cguw%3D%3D
30. S Pittock V Lennon de Seze, et al. 2008 Neuromyelitis optica and non-organ-specific autoimmunity Arch Neurol 65 1 78 83 18195142
31. T Harada T Ohashi C Harada, et al. 1997 A case of bilateral optic neuropathy and recurrent transverse myelopathy associated with perinuclear anti-neutrophil cytoplasmic antibodies (p-ANCA) J Neuroophthalmol 17 254 256 9427178 1:STN:280:DyaK1c%2FovVKitQ%3D%3D (Pubitemid 28016256)
32. A Mochizuki A Hayashi S Hisahara S Shoji 2000 Steroid-responsive Devic's variant in Sjögren's syndrome Neurology 54 6 1391 1392 10746622 1:STN:280:DC%2BD3cvgs1CrsQ%3D%3D (Pubitemid 30174071)
33. S Paira M Benegas A Ortiz 2010 Association of neuromyelitis optic (NMO) with autoimmune disorders: report of two cases and review of the literature Clin Rheumatol 29 1335 1338 In this article, the authors present two patients with NMO (Devic disease), one associated with SLE and the other with Hashimoto's thyroiditis. They emphasize the importance of ruling out other entities throughout the follow-up. NMO is seldom described in patients with lupus, which may be due to the rare occurrence of this association, sometimes leading to its misdiagnosis.
34. CF Lucchinetti RN Mandler D McGavern, et al. 2002 A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica Brain 125 1450 1461 12076996 (Pubitemid 34755161)
35. FC Stansbury 1949 Neuromyelitis optica (Devic's disease): presentation of five cases with pathologic study, and review of the literature Arch Ophthalmol 42 292 335 1:STN:280:DyaH1M%2Fkt1KgtQ%3D%3D
36. BG Weinshenker PC O'Brien TM Petterson, et al. 1999 A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease Ann Neurol 46 6 878 886 10589540 1:STN:280:DC%2BD3c%2FlsFCmtQ%3D%3D
37. BA Cree S Lamb K Morgan A Chen E Waubant C Genain 2005 An open label study of the effects of rituximab in neuromyelitis optica Neurology 64 7 1270 1272 15824362 1:CAS:528:DC%2BD2MXislSlsro%3D
38. SF Roemer JE Parisi VA Lennon, et al. 2007 Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis Brain 130 Pt 5 1194 1205 17282996 Epub 2007 Feb 4 (Pubitemid 47355941)
39. T Misu K Fujihara M Nakamura, et al. 2006 Loss of aquaporin-4 in active perivascular lesions in neuromyelitis optica: a case report Tohoku J Exp Med. 209 3 269 275 16778375 (Pubitemid 43905560)
40. M Matiello A Jacob DM Wingerchuk BG Weinshenker 2007 Neuromyelitis optica Curr Opin Neurol 20 3 255 260 17495617 (Pubitemid 46743105)
41. JT Tesar V McMillan R Molina J Armstrong 1992 Optic neuropathy and central nervous system disease associated with primary Sjögren's syndrome Am J Med 92 6 686 692 1605151 1:STN:280:DyaK383ps1SqtA%3D%3D
42. PM Williamson 1975 Neuromyelitis optica following infectious mononucleosis Proc Aust Assoc Neurol 12 153 155 1215384 1:STN:280: DyaE287isl2qtg%3D%3D
43. S Doutlik O Sblova R Kryl M Novak 1975 Neuromyelitis optica as a parainfectious complication of varicella Cesk Neurol Neurochir 38 238 242 1139706 1:STN:280:DyaE2M7osFKrtA%3D%3D
44. MJ Chusid SJ Williamson JV Murphy LS Ramey 1979 Neuromyelitis optica (Devic disease) following varicella infection J Pediatr 95 737 738 114615 1:STN:280:DyaL3c%2FivV2isQ%3D%3D (Pubitemid 10228532)
45. SM al-Deeb BA Yaqub WO Khoja 1993 Devic's neuromyelitis optica and varicella J Neurol 240 450 451 8410090 1:STN:280:DyaK2c%2FhsFWkuw%3D%3D
46. P Blanche E Diaz B Gombert D Sicard O Rivoal A Brezin 2000 Devic's neuromyelitis optica and HIV-1 infection J Neurol Neurosurg Psychiatry 68 795 796 10877625 1:STN:280:DC%2BD3czis1CnsQ%3D%3D (Pubitemid 30265290)
47. J Barbizet JD Degos C Meyrignac 1980 Acute neuromyelitis optica and acute pulmonary tuberculosis (author's trans.) Rev Neurol (Paris) 136 303 309 1:STN:280:DyaL3M%2FjtlClsw%3D%3D (Pubitemid 11226111)
48. RA Hughes WG Mair 1977 Acute necrotic myelopathy with pulmonary tuberculosis Brain 100 223 238 884483 1:STN:280:DyaE2s3itlSguw%3D%3D (Pubitemid 8130473)
49. MH Silber PA Willcox RM Bowen A Unger 1990 Neuromyelitis optica (Devic's syndrome) and pulmonary tuberculosis Neurology 40 934 938 2345617 1:STN:280:DyaK3c3msFGgsg%3D%3D (Pubitemid 20201819)
50. JC Vernant P Cabre D Smadja, et al. 1997 Recurrent optic neuromyelitis with endocrinopathies: a new syndrome Neurology 48 1 58 64 9008495 1:STN:280:DyaK2s7mtFagug%3D%3D (Pubitemid 27039518)
51. L Fardet T Généreau Y Mikaeloff B Fontaine D Seilhean J Cabane 2003 Devic's neuromyelitis optica: study of nine cases Acta Neurol Scand. 108 3 193 200 12911463 1:STN:280:DC%2BD3svhvFSltA%3D%3D (Pubitemid 37011649)
52. AY Poppe Y Lapierre D Melançon, et al. 2005 Neuromyelitis optica with hypothalamic involvement Mult Scler 11 5 617 621 16193902 (Pubitemid 41387709)
53. M Berman S Feldman M Alter N Zilber E Kahana 1981 Acute transverse myelitis: incidence and etiologic considerations Neurology 31 8 966 971 7196523 1:STN:280:DyaL3M3ntFWkuw%3D%3D (Pubitemid 11061734)
54. G Espinosa A Mendizábal S Mínguez, et al. 2010 Transverse myelitis affecting more than 4 spinal segments associated with systemic lupus erythematosus: clinical, immunological, and radiological characteristics of 22 patients Semin Arthritis Rheum. 39 4 246 256 19022478 Epub 2008 Nov 20. In this study, the main clinical and immunologic features of 22 patients, including 2 previously unreported cases, were compared with a group of 32 SLE patients with transverse myelitis affecting less than 4 spinal segments collected from 3 reported series.
55. C Lavalle S Pizarro C Drenkard J Sánchez-Guerrero D Alarcón-Segovia 1990 Transverse myelitis: a manifestation of systemic lupus erythematosus strongly associated with antiphospholipid antibodies J Rheumatol 17 1 34 37 2313670 1:STN:280:DyaK3c7ovFSltw%3D%3D (Pubitemid 20070564)
56. B Kovacs T Lafferty L Brent R DeHoratius 2000 Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature Ann Rheum Dis 59 120 124 10666167 1:STN:280:DC%2BD3c7ivFCgsg%3D%3D (Pubitemid 30305609)
57. Y Sherer S Hassin Y Shoenfeld, et al. 2002 Transverse myelitis in patients with antiphospholipid antibodies-the importance of early diagnosis and treatment Clin Rheumatol 21 207 210 12111625 1:STN:280:DC%2BD38zms1ejuw%3D%3D (Pubitemid 34785008)
58. DA Jabs NR Miller SA Newman MA Johnson MB Stevens 1986 Optic neuropathy in systemic lupus erythematosus Arch Ophthalmol 104 4 564 568 3954662 1:STN:280:DyaL287lvVCrsw%3D%3D (Pubitemid 16086345)
59. A Theodoridou L Settas 2006 Demyelination in rheumatic diseases J Neurol Neurosurg Psychiatry 77 290 295 16484634 1:STN:280:DC%2BD28%2FpslCqtg%3D%3D
60. AN Gibbs J Moroney D Foley-Nolan PG O'Connell 2002 Neuromyelitis optica (Devic's syndrome) in systemic lupus erythematosus: a case report Rheumatology (Oxford). 41 4 470 471 1:STN:280:DC%2BD383isFCmsQ%3D%3D (Pubitemid 34537851)
61. J Birnbaum D Kerr 2007 Devic's syndrome in a woman with systemic lupus erythematosus: diagnostic and therapeutic implications of testing for the neuromyelitis optica IgG autoantibody Arthritis Care Res 57 347 351 (Pubitemid 47164100)
62. MK Mathews 2005 Nonarteritic anterior ischemic optic neuropathy Curr Opin Ophthalmol 16 6 341 345 16264343 (Pubitemid 41735823)
63. J Birnbaum D Kerr 2008 Optic neuritis and recurrent myelitis in a woman with systemic lupus erythematosus Nat Clin Pract Rheumatol 4 7 381 386 18493269 Epub 2008 May 20 (Pubitemid 351974010)
64. AA Deodhar T Hochenedel RM Bennett 1999 Longitudinal involvement of the spinal cord in a patient with lupus related transverse myelitis J Rheumatol 26 446 449 9972984 1:STN:280:DyaK1M7jslaluw%3D%3D (Pubitemid 29066754)
65. JF Tellez-Zenteno JM Remes-Troche RO Negrete-Pulido, et al. 2001 Longitudinal myelitis associated with systemic lupus erythematosus: clinical features and magnetic resonance imaging of six cases Lupus 10 851 856 11787874 1:STN:280:DC%2BD38%2Fmt1ahtg%3D%3D (Pubitemid 34019215)
66. DP D'Cruz S Mellor-Pita B Joven G Sanna J Allanson J Taylor, et al. 2004 Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupus-like disease: good functional outcome and relevance of antiphospholipid antibodies J Rheumatol 31 280 285 14760797 (Pubitemid 38160749)
67. J de Seze T Stojkovic D Ferriby, et al. 2002 Devic's neuromyelitis optica: clinical, laboratory, MRI and outcome profile J Neurol Sci 197 1-2 57 61 11997067 (Pubitemid 34462145)
68. JH Min SH Kim MS Park, et al. 2010 Brain MRI lesions characteristic of neuromyelitis optica and positive anti-aquaporin 4-antibody may predict longitudinal extensive myelitis and optic neuritis in Sjögren's syndrome Mult Scler 16 6 762 764 20558506 A patient with Sjögren's syndrome had characteristic brain lesions of NMO with high titers of AQP4 antibodies before developing LETM and ON. This case suggests that brain lesions of NMO associated with systemic autoimmune disorders (especially Sjögren's syndrome) have to be included in the spectrum of NMO-related disorders.
69. D Squatrito S Colagrande L Emmi 2010 Devic's syndrome and primary APS: a new immunological overlap Lupus 19 1337 1339 20504834 1:STN:280: DC%2BC3cfktFChtg%3D%3D This case report describes a patient meeting the classification criteria for primary APS and the new diagnostic criteria for NMO. It is important to diagnose NMO syndrome, as both ON and transverse myelitis were also considered neurological complications of APS. NMO-IgG is a new and fundamental test to determine whether immunosuppressant therapy is recommended for such patients.
70. P Mottaghi F Ashtari H Karimzadeh Z Seidbonakdar M Karimifar M Salesi 2009 Devic's syndrome concomitant with nephritis in a young woman Clin Rheumatol 28 10 1239 1240 19649677 Epub 2009 Aug 1. The authors presented the case of a woman with blurred vision and the inability to walk due to acute ON, transverse myelitis, and NMO, an interesting presentation of this syndrome with proteinuria as the first manifestation of SLE.
71. A Protti C Erminio I Piccolo C Spreafico F Colombo A Ghezzi 2004 An unusual case with relapsing neuromyelitis optica associated with undifferentiated connective tissue disease Neurol Sci 25 Suppl 4 S383 S385 15727240 (Pubitemid 39600438)
72. RS April E Vansonnenberg 1976 A case of neuromyelitis optica (Devic's syndrome) in systemic lupus erythematosus. Clinicopathologic report and review of the literature Neurology 26 1066 1070 988514 1:STN:280:DyaE2s%2FjsV2qsg%3D%3D
73. C Jacobi K Stingele R Kretz M Hartmann B Storch-Hagenlocher A Breitbart, et al. 2006 Neuromyelitis optica (Devic's syndrome) as first manifestation of systemic lupus erythematosus Lupus 15 107 109 16539283 1:STN:280: DC%2BD287ltVGnsg%3D%3D (Pubitemid 43345337)
74. S Ferreira P Marques E Carneiro D D'Cruz G Gama 2005 Devic's syndrome in systemic lupus erythematosus and probable antiphospholipid syndrome Rheumatology 44 693 695 15695293 1:STN:280:DC%2BD2M3gs1yntw%3D%3D (Pubitemid 41487251)
75. N Hagiwara K Toyoda T Uwatoko K Yasumori S Ibayashi Y Okada 2005 Successful high dose glucocorticoid treatment for subacute neuromyelitis optica with systemic lupus erythematosus Intern Med 44 998 1001 16258221 (Pubitemid 41644105)
76. DJ Graber M Levy D Kerr WF Wade 2008 Neuromyelitis optica pathogenesis and aquaporin 4 J Neuroinflammation. 5 22 18510734
77. LR Mehta MK Samuelsson SR Schwid, et al. 2008 Neuromyelitis optica spectrum disorder in a patient with systemic lupus erythematosus and anti-phospholipid antibody syndrome Mult Scler 14 425 428 18208886
78. BG Weinshenker 2007 Neuromyelitis optica is distinct from multiple sclerosis Arch Neurol 64 6 899 901 17562942 (Pubitemid 46919849)
79. BG Weinshenker DM Wingerchuk S Vukusic, et al. 2006 Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis Ann Neurol 59 3 566 569 16453327 1:CAS:528:DC%2BD28XjtV2ltrY%3D (Pubitemid 43358081)
80. S Ferreira DP D'Cruz GR Hughes 2005 Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand? Rheumatology (Oxford) 44 4 434 442 1:CAS:528:DC%2BD2MXisVGqtrs%3D Epub 2005 Jan 11 (Pubitemid 41511130)
81. D Karussis RR Leker A Ashkenazi O Abramsky 1998 A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: do they represent a new nosological entity? Ann Neurol 44 629 634 9778261 1:STN:280:DyaK1cvkvFOisg%3D%3D (Pubitemid 28477850)
82. A Katzav Y Shoenfeld J Chapman 2010 The pathogenesis of neural injury in animal models of the antiphospholipid syndrome Clin Rev Allergy Immunol 38 196 200 19557316 1:CAS:528:DC%2BC3cXktVCgurg%3D In this article, the authors propose a logical pathway for how experimental APS causes brain dysfunction. The diffuse brain endothelial dysfunction would result in extravasations of serum proteins, including APS-IgG and activated thrombin, which may induce the behavioral changes observed in the APS mice. They collected data from the mouse experimental APS model that support this hypothesis.
83. DM Wingerchuk VA Lennon CF Lucchinetti SJ Pittock BG Weinshenker 2007 The spectrum of neuromyelitis optica Lancet Neurol. 6 9 805 815 17706564 1:CAS:528:DC%2BD2sXhtVyrsrrO (Pubitemid 47238676)
84. DM Wingerchuk BG Weinshenker 2005 Neuromyelitis optica Curr Treat Options Neurol. 7 3 173 182 15814070 (Pubitemid 40894929)
85. S Watanabe I Nakashima T Misu, et al. 2007 Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica Mult Scler 13 1 128 132 17294622 1:STN:280:DC%2BD2s%2Fps1KntA%3D%3D (Pubitemid 46152772)
86. M Keegan AA Pineda RL McClelland CH Darby M Rodriguez BG Weinshenker 2002 Plasma exchange for severe attacks of CNS demyelination: predictors of response Neurology 58 1 143 146 11781423 1:STN:280:DC%2BD38%2FlsF2rsg%3D%3D
87. RN Mandler W Ahmed JE Dencoff 1998 Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine Neurology 51 1219 1220 9781568 1:STN:280:DyaK1cvlt1yhug%3D%3D (Pubitemid 28473439)
88. F Falcini S Trapani L Ricci M Resti G Simonini M de Martino 2006 Sustained improvement of a girl affected with Devic's disease over 2 years of mycophenolate mofetil treatment Rheumatology (Oxford) 45 7 913 915 1:STN:280:DC%2BD28zotlSgsA%3D%3D Epub 2006 Apr 25 (Pubitemid 43985386)
89. A Jacob M Matiello BG Weinshenker, et al. 2009 Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients Arch Neurol 66 9 1128 33 19752302 In this study, the efficacy and safety of mycophenolate mofetil therapy in 24 patients with NMOSDs were evaluated. The authors concluded that mycophenolate is associated with reduction in relapse frequency and stable or reduced disability in patients with NMOSDs.
90. A Minagar WA Sheremata 2000 Treatment of Devic's disease with methotrexate and prednisone Int J MS Care 2 39 43
91. CC Mok CH To A Mak WL Poon 2008 Immunoablative cyclophosphamide for refractory lupus-related neuromyelitis optica J Rheumatol 35 1 172 174 18176991
92. S Nasir DA Kerr J Birnbaum 2009 Nineteen episodes of recurrent myelitis in a woman with neuromyelitis optica and systemic lupus erythematosus Arch Neurol 66 9 1160 3 19752308 Ongoing B-cell stimulation may have led to activation of the cellular arm of the immune system during earlier attacks and contributed to treatment intractability to rituximab during later attacks.
93. B Weinstock-Guttman M Ramanathan N Lincoff, et al. 2006 Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (Devic disease) Arch Neurol 63 7 957 963 16831964 (Pubitemid 44036296)
94. JM Fidler SQ DeJoy FR Smith III JJ Gibbons Jr 1986 Selective immunomodulation by the antineoplastic agent mitoxantrone, II: nonspecific adherent suppressor cells derived from mitoxantrone-treated mice J Immunol 136 2747 2754 2937837 1:CAS:528:DyaL28XktVSht70%3D (Pubitemid 16107173)
95. A Jacob B Weinshenker I Violich, et al. 2008 Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients Arch Neurol 65 1443 1448 18779415
96. HJ Kim W Kim MS Park, et al. 2009 B cell depletion therapy using rituximab in neuromyelitis optica spectrum disorders Mult Scler 15 S 253 Twenty-seven patients with NMO treated prospectively received multiple infusions of rituximab for up to 2 years to assess the safety and efficacy of this agent.